Skip to content
Review Open access

Artificial intelligence-assisted lead optimization in drug discovery: bridging computational advances and translational challenges.

Sep 2026 · Medicinal Chemistry Research · 0 citations · 74 references
Medicine

TL;DR

It is concluded that future progress will depend less on increasingly sophisticated algorithms than on trustworthy AI systems that improve scientific decision-making within iterative lead optimization workflows and ultimately enhance translational success in drug discovery.

Read PDF

Similar papers

Review 2026

Artificial Intelligence in Drug Discovery: Translational Bottlenecks, Biomedical Engineering Constraints, and Commercial Realities

The analysis suggests that AI will become an increasingly important component of pharmaceutical workflows; however, long-term impact will depend less on algorithmic advancement alone and more on effective integration with biological validation, experimental rigor, clinical evidence, and scalable translational infrastru...

Andrew Matelis · 0 citations
Review Sep 2026

Revolution of Computer-assisted Drug Design: The Transformative Role of Artificial Intelligence.

Artificial intelligence (AI) is transforming computer-aided drug design (CADD) by enabling more rapid, efficient, and data-driven approaches to drug discovery. This narrative review examines recent applications of AI, machine learning (ML), deep learning (DL), reinforcement learning (RL), natural language processing (N...

Uma Rawat, Anita Singh · 0 citations
Review Open access Aug 2026

Artificial Intelligence in Drug Discovery and Medicinal Chemistry: A Review

This review examines the available literature from human clinical studies, computational drug discovery research, systematic reviews, meta-analyses, and clinical investigations, highlighting the applications of AI in target identification, virtual screening, lead optimization, drug repurposing, ADMET prediction, and pr...

Neha Arora, Yogesh Matta, Monu Kumar et al. · 0 citations
Review Sep 2026

Precision Drug Discovery in the Era of Artificial Intelligence: A Critical Review.

A paradigm shift toward autonomous scientific agents capable of causal reasoning and end-to-end experimental guidance is highlighted, and persistent challenges are discussed, including data bias, limited interpretability, and in silico-to-wet lab translation.

Meng Liu, Jia-Cheng Xiong, Ming-Yue Zheng · 0 citations
Review Open access Sep 2026

APPLICATIONS OF DATA ANALYSIS AND ARTIFICIAL INTELLIGENCE AGENTS IN NOVEL DRUG DISCOVERY: A CRITICAL LITERATURE REVIEW

This evidence-based literature review critically examines the evolution and application of computational technologies across the pharmaceutical pipeline, ranging from early expert systems like DENDRAL, computer-aided drug design (CADD), and quantitative structure-activity relationship (QSAR) modeling to AlphaFold 3 bio...

Leonardo Mairene Muniz · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.